Vericel Corporation (VCEL) Insider Trading

Last 12 months

Insiders sold $7.89M and bought nothing on the open market.

93% of the selling was scheduled in advance under 10b5-1 plans. Director Paul K Wotton sold $327k on May 11, 35% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2018.

Net open-market

−$7.89M

0 buys · 25 sales

Under a 10b5-1 plan

93%

of the value sold

Insiders who bought / sold

0 / 8

executives and directors

Last open-market buy

Mar 2018

Mar 16, 2018

Get an email when VCEL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 12	Kevin F McLaughlin Director	Sold10b5-1 plan	7,000	$44.53	$312k	28%	Form 4
Aug 3	Michael Halpin Chief Operating Officer	Sold10b5-1 plan	10,000	$46.84	$468k	38%	Form 4
Jul 30	Jonathan Siegal Principal Accounting Officer	Sold10b5-1 plan 3 parts	4,500	$48.90 average	$220k	81%	Form 4
Jun 26	Jonathan Siegal Principal Accounting Officer	Sold10b5-1 plan 2 parts	2,732	$44.90 average	$123k	76%	Form 4
Jun 26	Joseph Anthony Mara Jr Chief Financial Officer	Sold10b5-1 plan	5,000	$44.75	$224k	24%	Form 4
Jun 26	Jonathan Mark Hopper Chief Medical Officer	Sold10b5-1 plan 2 parts	10,000	$45.00 average	$450k	12%	Form 4
Jun 26	Sean C. Flynn Chief Legal Officer	Sold10b5-1 plan	15,000	$45.64	$685k	90%	Form 4
Jun 18	Michael Halpin Chief Operating Officer	Sold10b5-1 plan	10,000	$40.24	$402k	38%	Form 4
Jun 18	Sean C. Flynn Chief Legal Officer	Sold10b5-1 plan	15,000	$40.21	$603k	90%	Form 4
Jun 2	Jonathan Mark Hopper Chief Medical Officer	Sold10b5-1 plan	4,375	$35.00	$153k	5.5%	Form 4
May 13	Kevin F McLaughlin Director	Sold10b5-1 plan 2 parts	7,000	$32.83 average	$230k	28%	Form 4
May 11	Paul K Wotton Director	SoldNo plan 2 parts	10,000	$32.74 average	$327k	35%	Form 4
May 7	Joseph Anthony Mara Jr Chief Financial Officer	Sold10b5-1 plan	5,000	$40.50	$203k	19%	Form 4
May 6 – 7	Jonathan Siegal Principal Accounting Officer	Sold10b5-1 plan 2 parts	4,855	$38.73 average	$188k	81%	Form 4
Apr 2	Jonathan Mark Hopper Chief Medical Officer	Sold10b5-1 plan	3,472	$35.00	$122k	4.4%	Form 4
Mar 23	Heidi Hagen Director	Sold10b5-1 plan	15,000	$32.41	$486k	32%	Form 4
Mar 2	Sean C. Flynn Chief Legal Officer	Sold10b5-1 plan 2 parts	21,421	$35.18 average	$754k	94%	Form 4
Mar 2	Michael Halpin Chief Operating Officer	Sold10b5-1 plan	10,305	$35.30	$364k	39%	Form 4
Feb 11	Kevin F McLaughlin Director	Sold10b5-1 plan	7,000	$34.66	$243k	32%	Form 4
Jan 7	Michael Halpin Chief Operating Officer	Sold10b5-1 plan	10,000	$40.48	$405k	38%	Form 4
Dec 2, 2025 – Dec 3, 2025	Paul K Wotton Director	SoldNo plan 2 parts	5,000	$37.90 average	$190k	16%	Form 4
Dec 2, 2025	Jonathan Mark Hopper Chief Medical Officer	Sold10b5-1 plan	1,652	$39.14	$65k	2.4%	Form 4
Nov 11, 2025	Michael Halpin Chief Operating Officer	Sold10b5-1 plan	2,642	$40.41	$107k	14%	Form 4
Nov 10, 2025	Kevin F McLaughlin Director	Sold10b5-1 plan	7,000	$38.59	$270k	32%	Form 4
Nov 6, 2025	Michael Halpin Chief Operating Officer	Sold10b5-1 plan	7,358	$40.47	$298k	32%	Form 4
Sep 2, 2025	Jonathan Mark Hopper Chief Medical Officer	Sold10b5-1 plan	10,000	$35.77	$358k	13%	Form 4
Aug 6, 2025	Kevin F McLaughlin Director	Sold10b5-1 plan	7,000	$35.92	$251k	32%	Form 4
Jun 2, 2025	Jonathan Mark Hopper Chief Medical Officer	Sold10b5-1 plan	10,000	$40.09	$401k	13%	Form 4
May 14, 2025 – May 15, 2025	Dominick Colangelo President and CEO	Sold10b5-1 plan 2 parts	28,125	$41.89 average	$1.18M	9.7%	Form 4
May 7, 2025	Kevin F McLaughlin Director	Sold10b5-1 plan	7,000	$39.98	$280k	32%	Form 4
Apr 9, 2025 – Apr 10, 2025	Dominick Colangelo President and CEO	Sold10b5-1 plan 2 parts	49,700	$41.50 average	$2.06M	16%	Form 4
Mar 12, 2025 – Mar 13, 2025	Dominick Colangelo President and CEO	Sold10b5-1 plan 2 parts	53,183	$46.04 average	$2.45M	17%	Form 4
Mar 3, 2025	Michael Halpin Chief Operating Officer	Sold10b5-1 plan	10,000	$49.52	$495k	39%	Form 4
Mar 3, 2025	Heidi Hagen Director	Sold10b5-1 plan	9,000	$49.53	$446k	24%	Form 4
Mar 3, 2025	Joseph Anthony Mara Jr Chief Financial Officer	Sold10b5-1 plan	9,000	$49.53	$446k	39%	Form 4
Mar 3, 2025	Jonathan Mark Hopper Chief Medical Officer	Sold10b5-1 plan	10,000	$49.53	$495k	13%	Form 4
Feb 25, 2025	Sean C. Flynn Chief Legal Officer	Sold10b5-1 plan	1,669	$52.07	$87k	69%	Form 4
Feb 25, 2025	Jonathan Siegal Principal Accounting Officer	Sold10b5-1 plan	1,137	$52.07	$59k	49%	Form 4
Feb 20, 2025	Sean C. Flynn Chief Legal Officer	Sold10b5-1 plan	3,835	$57.32	$220k	84%	Form 4
Feb 19, 2025	Jonathan Siegal Principal Accounting Officer	Sold10b5-1 plan	1,710	$56.72	$97k	59%	Form 4

Aug 1210b5-1 plan
Kevin F McLaughlin
Director · sold 7,000 at $44.53
$312k
28% of stake
Aug 310b5-1 plan
Michael Halpin
Chief Operating Officer · sold 10,000 at $46.84
$468k
38% of stake
Jul 3010b5-1 plan
Jonathan Siegal
Principal Accounting Officer · sold 4,500 at avg $48.90
$220k
81% of stake
Jun 2610b5-1 plan
Jonathan Siegal
Principal Accounting Officer · sold 2,732 at avg $44.90
$123k
76% of stake
Jun 2610b5-1 plan
Joseph Anthony Mara Jr
Chief Financial Officer · sold 5,000 at $44.75
$224k
24% of stake
Jun 2610b5-1 plan
Jonathan Mark Hopper
Chief Medical Officer · sold 10,000 at avg $45.00
$450k
12% of stake
Jun 2610b5-1 plan
Sean C. Flynn
Chief Legal Officer · sold 15,000 at $45.64
$685k
90% of stake
Jun 1810b5-1 plan
Michael Halpin
Chief Operating Officer · sold 10,000 at $40.24
$402k
38% of stake
Jun 1810b5-1 plan
Sean C. Flynn
Chief Legal Officer · sold 15,000 at $40.21
$603k
90% of stake
Jun 210b5-1 plan
Jonathan Mark Hopper
Chief Medical Officer · sold 4,375 at $35.00
$153k
5.5% of stake
May 1310b5-1 plan
Kevin F McLaughlin
Director · sold 7,000 at avg $32.83
$230k
28% of stake
May 11No plan
Paul K Wotton
Director · sold 10,000 at avg $32.74
$327k
35% of stake
May 710b5-1 plan
Joseph Anthony Mara Jr
Chief Financial Officer · sold 5,000 at $40.50
$203k
19% of stake
May 6 – 710b5-1 plan
Jonathan Siegal
Principal Accounting Officer · sold 4,855 at avg $38.73
$188k
81% of stake
Apr 210b5-1 plan
Jonathan Mark Hopper
Chief Medical Officer · sold 3,472 at $35.00
$122k
4.4% of stake
Mar 2310b5-1 plan
Heidi Hagen
Director · sold 15,000 at $32.41
$486k
32% of stake
Mar 210b5-1 plan
Sean C. Flynn
Chief Legal Officer · sold 21,421 at avg $35.18
$754k
94% of stake
Mar 210b5-1 plan
Michael Halpin
Chief Operating Officer · sold 10,305 at $35.30
$364k
39% of stake
Feb 1110b5-1 plan
Kevin F McLaughlin
Director · sold 7,000 at $34.66
$243k
32% of stake
Jan 710b5-1 plan
Michael Halpin
Chief Operating Officer · sold 10,000 at $40.48
$405k
38% of stake
Dec 2, 2025 – Dec 3, 2025No plan
Paul K Wotton
Director · sold 5,000 at avg $37.90
$190k
16% of stake
Dec 2, 202510b5-1 plan
Jonathan Mark Hopper
Chief Medical Officer · sold 1,652 at $39.14
$65k
2.4% of stake
Nov 11, 202510b5-1 plan
Michael Halpin
Chief Operating Officer · sold 2,642 at $40.41
$107k
14% of stake
Nov 10, 202510b5-1 plan
Kevin F McLaughlin
Director · sold 7,000 at $38.59
$270k
32% of stake
Nov 6, 202510b5-1 plan
Michael Halpin
Chief Operating Officer · sold 7,358 at $40.47
$298k
32% of stake
Sep 2, 202510b5-1 plan
Jonathan Mark Hopper
Chief Medical Officer · sold 10,000 at $35.77
$358k
13% of stake
Aug 6, 202510b5-1 plan
Kevin F McLaughlin
Director · sold 7,000 at $35.92
$251k
32% of stake
Jun 2, 202510b5-1 plan
Jonathan Mark Hopper
Chief Medical Officer · sold 10,000 at $40.09
$401k
13% of stake
May 14, 2025 – May 15, 202510b5-1 plan
Dominick Colangelo
President and CEO · sold 28,125 at avg $41.89
$1.18M
9.7% of stake
May 7, 202510b5-1 plan
Kevin F McLaughlin
Director · sold 7,000 at $39.98
$280k
32% of stake
Apr 9, 2025 – Apr 10, 202510b5-1 plan
Dominick Colangelo
President and CEO · sold 49,700 at avg $41.50
$2.06M
16% of stake
Mar 12, 2025 – Mar 13, 202510b5-1 plan
Dominick Colangelo
President and CEO · sold 53,183 at avg $46.04
$2.45M
17% of stake
Mar 3, 202510b5-1 plan
Michael Halpin
Chief Operating Officer · sold 10,000 at $49.52
$495k
39% of stake
Mar 3, 202510b5-1 plan
Heidi Hagen
Director · sold 9,000 at $49.53
$446k
24% of stake
Mar 3, 202510b5-1 plan
Joseph Anthony Mara Jr
Chief Financial Officer · sold 9,000 at $49.53
$446k
39% of stake
Mar 3, 202510b5-1 plan
Jonathan Mark Hopper
Chief Medical Officer · sold 10,000 at $49.53
$495k
13% of stake
Feb 25, 202510b5-1 plan
Sean C. Flynn
Chief Legal Officer · sold 1,669 at $52.07
$87k
69% of stake
Feb 25, 202510b5-1 plan
Jonathan Siegal
Principal Accounting Officer · sold 1,137 at $52.07
$59k
49% of stake
Feb 20, 202510b5-1 plan
Sean C. Flynn
Chief Legal Officer · sold 3,835 at $57.32
$220k
84% of stake
Feb 19, 202510b5-1 plan
Jonathan Siegal
Principal Accounting Officer · sold 1,710 at $56.72
$97k
59% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VCEL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Biological Products, (No Diagnostic Substances)

ADPTAdaptive Biotechnologies Corporation

IOVAIovance Biotherapeutics, Inc.

VXRTVaxart Inc.

TWSTTwist Bioscience Corporation

IMCRImmunocore Holdings plc

KRYSKrystal Biotech Inc.

BEAMBeam Therapeutics Inc.

DNAGinkgo Bioworks Holdings Inc.

Spot a number that looks wrong? Check it in VCEL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VCEL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.